Tissue specific patterns of methylated cytosine residues vary with age, can be altered by
environmental factors, and are often abnormal in human disease yet the cellular consequences …

Transforming growth factor β (TGFβ) is one of few known negative regulators of hematopoiesis,
yet the mechanisms by which it affects cell cycle arrest and stem cell quiescence are …

Generating engraftable human haematopoietic cells from autologous tissues is a potential
route to new therapies for blood diseases. However, directed differentiation of pluripotent …

Developmental pathways that orchestrate the fleeting transition of endothelial cells into
haematopoietic stem cells remain undefined. Here we demonstrate a tractable approach for fully …

Defining the transcriptomic identity of malignant cells is challenging in the absence of
surface markers that distinguish cancer clones from one another, or from admixed non-neoplastic …

Tumor endothelial cells (ECs) promote cancer progression in ways beyond their role as
conduits supporting metabolism. However, it is unknown how vascular niche-derived paracrine …

Inactivation of the von Hippel-Lindau tumor suppressor gene, VHL, is an archetypical tumor-initiating
event in clear cell renal carcinoma (ccRCC) that leads to the activation of hypoxia-…

Abstract Treatment options for older patients with acute myeloid leukemia (AML) and for
patients with relapsed/refractory AML are limited, and outcomes are poor. Decitabine, a …

We conducted an open-label phase 1 study exploring the feasibility, safety, and biologic
activity of epigenetic priming with decitabine before standard induction chemotherapy in …

Tumor-associated endothelial cells (TECs) regulate tumor cell aggressiveness. However, the
core mechanism by which TECs confer stem cell-like activity to indolent tumors is unknown…